SEC Rules are expected this Spring to affect SPAC offerings; last week the SEC’s Investor Advisory Committee provided the Commission with a list of recommendations for consideration. These recommendations focus primarily on enhanced disclosures: use of financial projections (generally omitted … Continue reading
Tag Archives: SPACs
SPACs are under attack in litigation file in New York Federal Court, claiming these entities should be closely regulated as investment companies under the ’40 Act. SPACs typically invest their funds in market securities during they year or more they … Continue reading
A week ago, panelists at an ambitious program mounted by the Boston Bar Association took a broad look at major trends in life science deals and risks. Some interesting highlights follow. Did COVID hurt or help life science dealmaking? Both; … Continue reading